Ignite Creation Date:
2024-05-06 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05263570
Status:
RECRUITING
Last Update Posted:
2022-09-13
First Post:
2022-01-17
Brief Title:
The Efficiency for Stage II-III HRHER2 Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World
Sponsor:
Shengjing Hospital
Organization:
Shengjing Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| standard Therapy TCbHPTHPEC-THPAC-THP | View |